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Linolenic acid prevents neuronal cell death and
paraplegia after transient spinal cord ischemia in
rats
Loı¨c Lang-Lazdunski, MD, PhD,a,b Nicolas Blondeau, PhD,b Gise`le Jarretou, BS,b Michel Lazdunski,
PhD, DSc, and Catherine Heurteaux, PhD,b Clamart and Valbonne, France
Purpose: Spinal cord ischemia is a devastating complication of thoracic and thoracoabdominal aortic surgery. Recent
studies have suggested a neuroprotective effect of polyunsaturated fatty acids against cerebral ischemia. We investigated
the effect of linolenic acid (LIN) in a rat model of spinal cord ischemia.
Methods: Rats were subjected to cross-clamping of the aortic arch and left subclavian artery for 14 minutes. Groups were
as follows: sham operation (n  15); ischemia (n  15), receiving only vehicle; LIN A (n  15), receiving LIN before
clamping; and LIN B (n  15), receiving LIN at onset of reperfusion. Neurologic status was assessed daily for 7 days.
Spinal cords were harvested for histopathologic analysis, TUNEL staining, and immunohistochemistry for Bax, heat
shock protein 70 (HSP70), and nuclear factor–B.
Results: Ischemic rats had severe and definitive paraplegia. LIN-treated rats had significantly better neurologic function.
Histopathologic analysis disclosed severe neuronal necrosis in the lumbar gray matter of ischemic rats, whereas most of
the LIN-treated rats sustained mild to moderate injury. LIN reduced the loss of motor neurons at 7 days (LIN A, 17 
6, and LIN B, 15  7, versus ischemia, 6  2 per section; P < .05). LIN prevented apoptotic neuronal cell death, Bax
immunoreactivity of the pro-apoptotic protein Bax, and the nuclear transcription factor NF-B. Nuclear HSP70
immunoreactivity was noted exclusively in motor neurons from LIN-treated rats and not in motor neurons from ischemic
rats.
Conclusion: These results suggest that LIN can induce protection against ischemia in the spinal cord, thereby preventing
both necrosis and apoptosis of motor neurons. (J Vasc Surg 2003;38:564-75.)
Spinal cord ischemia with resulting paraplegia is a dev-
astating complication after repair of thoracoabdominal aor-
tic aneurysm or type B aortic dissection.1,2 Pharmacologic
spinal cord protection is emerging as a promising approach
to decrease the incidence of neurologic complications after
major aortic surgery.3,4 This approach depends on neither
aortic lesion nor spinal cord arterial vascularization. More-
over, this approach can be combined with other protective
measures, such as use of atriofemoral bypass grafting, cere-
brospinal fluid drainage, and local or systemic hypother-
mia.1,2
Recent studies suggest that polyunsaturated fatty acids
(PUFA) are potent neuroprotectors and might have a
beneficial effect on various brain functions, such as epileptic
seizures and cerebral ischemia.5,6 The purpose of this study
was to determine whether the PUFA linolenic acid (LIN;
18:3) could consistently prevent spinal cord injury and
improve neurologic outcome in a rat model of transient
spinal cord ischemia induced with aortic cross-clamping
and to analyze whether this drug could prevent necrotic or
apoptotic neuronal cell death in spinal cord gray matter.
MATERIAL AND METHODS
Animal care. Sprague-Dawley male rats weighing 350
to 400 g were used in this study. All animals were allowed
free access to laboratory chow and tap water in day or night
regulated quarters at 25°C. The study was approved by the
Institutional Review Board, and all animals received hu-
mane care in compliance with the Guide for the Care and
Use of Laboratory Animals, Institute of Laboratory Animal
Resources, Commission on Life Sciences, National Re-
search Council.
Surgical procedure. Anesthesia was induced in a
chamber containing 3% halothane and was maintained by
inhalation through a face mask of 1.5% halothane driven by
oxygen, 2 L/min. Body temperature was continuously
monitored and supported with a thermal pad and a heating
lamp. Body temperature was maintained at 37°C  0.5°C
during the surgical procedure. The rats were placed in the
supine position, and a longitudinal incision was made
through the skin in the sternal region. The left jugular vein
was used for intravenous injection of drugs or vehicle. The
chest wall was incised from the apex of the manubrium
caudad along the left sternal border to the third rib. The
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thymus was retracted superiorly, and the aortic arch was
isolated between the left common carotid artery and the left
subclavian artery, avoiding the left recurrent laryngeal
nerve. Spinal cord ischemia was induced with aortic arch
plus left subclavian artery cross-clamping for 14 minutes,
using two Micro Vessel Clips (Biomedical Research Instru-
ments, Rockville, Md). Then the clips were removed, and
the chest was closed in layers. The sham operation was
identical to the surgical procedure except for aortic arch
and left subclavian artery clamping. Animals were allowed
to recover in a plastic box at 28°C for 3 hours, then were
placed in their cages. The Crede´ maneuver was used twice
daily to empty the urinary bladder of paraplegic animals.
Study groups. Animals were separated into four dif-
ferent groups, as follows:
1. Sham operation (n  15): operation was performed
with similar conditions except for aortic and subclavian
artery clamping.
2. Ischemia (n  15): animals received only vehicle.
3. LIN A (n  15): linolenic acid, 250 nmol/kg, was
injected intravenously 30 minutes before aortic clamp-
ing.
4. LIN B (n  15): linolenic acid, 250 nmol/kg, was
injected intravenously at the onset of reperfusion.
All rats received a similar volume of solution, 1 mL for
all procedures. LIN (Sigma-Aldrich, St Quentin Fallavier,
France) was first dissolved in ethanol at molar concentra-
tion, then diluted in saline solution.
Sixty rats were assigned to survive for 7 days (n 15 per
group) in the first experiment, and 20 rats (n  5 per
group) were assigned to be killed at 24 hours in a second
experiment.
Measurement of mean distal arterial blood pressure
and blood gases. A 24-gauge intravenous catheter was
inserted in the tail artery and connected via a transducer to
a pressure monitor (Hewlett-Packard, Palo Alto, Calif).
Distal arterial blood pressure was monitored continuously
throughout the procedure. The catheter was removed after
30 minutes of reperfusion, and the tail incision was closed.
Arterial blood gases were measured from samples (0.5
mL) obtained from the tail artery. pH, partial arterial
oxygen tension (PaO2), and partial pressure of carbon
dioxide in arterial blood (PaCO2) were measured 10 min-
utes before ischemia and after 10 minutes of reperfusion.
Evaluation of neurobehavioral outcome. Serial as-
sessments of motor and sensory functions in the hind limbs
of all rats were performed at 24 hours, and daily up to 7 days
of reperfusion, using the score of LeMay et al7 with modi-
fications.
A. Walking with lower extremities
0. Normal
1. Toes flat under body when walking, but ataxia
present
2. Knuckle walking
3. Movement in lower extremities, but unable to
knuckle walk
4. No movement, drags lower extremities
B. Pain sensation
0. Normal, withdrawal to toe pinch
1. Squeals to toe pinch, but does not withdraw
2. No reaction to toe pinch
A motor sensory deficit index (MSDI) was calculated
for each animal at each time point. The final index was the
sum of the scores A and B, and the maximum deficit was
indicated by a score of 6.
Euthanasia. In the first experiment, animals (n  15
per group) were assigned to be killed at 7 days. Animals
were anesthetized with 3% halothane and transcardially
perfused with 100 mL of 0.9% saline solution at 4°C,
followed by 50 mL of fresh 4% paraformaldehyde. Spinal
cords were quickly harvested and placed in fresh 4% para-
formaldehyde at 4°C for 48 hours before being embedded
in paraffin.
In the second experiment, animals (n  5 per group)
were killed and perfused in the same way after 24 hours of
reperfusion. Spinal cords were quickly harvested and imme-
diately frozen in isopentane at 40°C, and stored at
70°C until use.
Histopathology. Spinal cords were removed from 4%
paraformaldehyde after 48 hours of fixation. Specimens
were dehydrated in 95% alcohol for 30 minutes, followed
by four changes of 100% alcohol for 1 hour each and five
changes of toluene for 1 hour each under vacuum at 37°C.
Spinal cords were infiltrated with paraffin and embedded in
paraffin at 57°C under vacuum and pressure. Transverse
sections were made on a microtome (Leica, Rueil-Malmai-
son France). Ten micrometer sections were obtained
through the lumbar spinal cord. For each lumbar spinal
cord studied (n  15 per group), three sections (10 m)
were placed on 3-aminopropylethoxysilane–coated slides,
and 10 slides (randomly chosen) per rat were stained with
cresyl violet. Each stained section was analyzed with a Leica
Aristoplan photomicroscope at 100 and 250 magnifi-
cation. The number of damaged neurons in each lumbar
spinal cord section was counted with the Rexed8 cytoarchi-
tectonic classification to describe the location of damaged
neurons in gray matter. A mean value for each spinal cord
section was obtained from 10 bilateral measurements on
three sections per slide and 10 slides per rat. The density of
damaged neurons for a given animal represents the average
of both right and left neuronal cell densities. Neuronal
density values were expressed as mean  SEM. Statistical
analysis of damaged neurons was performed with analysis of
variance, followed by Tukey w test for multiple compari-
sons. P  .05 was considered statistically significant. The
same protocol was used for calculating the mean number of
viable motor neurons in each animal. The neuropathologist
who performed the examinations was blinded to the exper-
imental conditions.
TUNEL staining. Transverse 10-m sections were
used and processed according to the TUNEL method as
described by Gavrieli et al.9 The in situ cell death detection
kit (Hoffmann-La Roche Ltd, Basel, Switzerland) and Vec-
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taStain ABC kit (Vector Laboratories, Burlingame, Calif)
were used for this purpose. Cells with nuclei frankly stained
with the TUNEL method or containing apoptotic bodies
were considered apoptotic. Neurons with nuclei that exhib-
ited faint TUNEL staining and that did not contain apop-
totic bodies were considered necrotic. Apoptotic TUNEL-
positive cells were counted with the same protocol
described above for necrotic cells on cresyl violet sections.
Immunohistochemistry for heat shock protein 70
(HSP70) and Bax protein. Ten micrometer thick cryo-
sections were immersed in 0.3% H2O2/methanol for 30
minutes, then immersed in 0.3% H2O2/phosphate-
buffered saline solution (PBS) for 15 minutes. After perme-
abilization in 0.3% Tween/PBS for 5 minutes, sections
were blocked with 1% goat serum (Vector Laboratories) for
4 hours at room temperature, followed by a single rinse in
PBS. Sections were then incubated with the primary anti-
body overnight. The antiserum used was rabbit polyclonal
HSP70 antibody (diluted 1:200; Euromedex, Mundol-
sheim, France) or the rabbit polyclonal Bax antibody (di-
luted 1:200; Santa Cruz Biotechnology, Santa Cruz, Calif).
After the primary incubation and three rinses in PBS 1X,
sections were incubated in biotinylated horse anti-rabbit
immunoglobulin G (diluted 1:100; Vector Laboratories)
for 2 hours. HSP70 and Bax expression was visualized
with dimethylamine benzedime–nickel staining using the
VectaStain ABC kit (Vector Laboratories). All sections
were washed in PBS 1X and then in distilled water, and
mounted with Entellan mounting media (Merck, Darm-
stadt, Germany).
Immunohistochemistry for nuclear factor–B. Fro-
zen sections (10 m) were postfixed with acetone for 10
minutes at 20°C. Sections were then immersed in 0.3%
H2O2/methanol for 30 minutes, permeabilized in 0.3%
Tween/PBS for 5 minutes, treated for 10 minutes in a
microwave oven in 0.1 mol/L citrate buffer (pH 6.0), and
blocked with 1% horse or goat serum (Vector Laboratories)
for 4 hours at room temperature. Sections were then incu-
bated with the mouse monoclonal antibody raised against
the active form of nuclear factor–B (NF-B, diluted
1:150; Chemicon, Temecula, Calif) overnight at 4°C. After
the primary incubation and three rinses in PBS 1X, sections
were incubated in biotinylated horse anti-mouse immuno-
globulin G (diluted 1:1000; Jackson ImmunoResearch,
Bar Harbour, Me) for 2 hours. Immunohistochemical ex-
pressions were visualized with DAB/DAB-Ni staining with
the VectaStain ABC kit (Vector Laboratories). All sections
were washed in distilled water and mounted with Entellan
mounting media.
Statistical analysis. Statistical analysis of measured
physiologic data was performed with one-way analysis of
variance. All physiologic data are expressed as mean  SE.
Neurologic scores were analyzed with the Kruskal-Wallis
test, followed by the Mann-Whitney U test when signifi-
cant. Differences were considered statistically significant at
P  .05.
RESULTS
Neurobehavioral outcome. There was no significant
difference in physiologic parameters between ischemic rats
and LIN-treated rats (Table I). Two rats in the control
group and one in the LIN A group died postoperatively. If
those rats are included, the mortality rate is 11.8% (2 of 17)
in the control group and 6.2% (1 of 16) in the LIN A
group. Those rats were replaced by other rats to maintain
the appropriate number in each group. All other rats sur-
vived the entire assigned observation period.
Table I. Physiologic parameters
Sham operation
(n  15)
Ischemia
(n  15)
Lin A*
(n  15)
Lin B†
(n  15)
MABP (mm Hg)‡
Preischemia 97  6 94  4 93  7 96  5
5 minutes after ischemia 9.5  1 9.5  1 10  1
30 minutes after reperfusion 86  2* 61  4 67  3 66  4
Rectal temperature (°C)
Preischemia 37.6  0.4 37.6  0.5 37.5  0.3 37.5  0.4
End ischemia 37.5  0.3 37.5  0.4 37.6  0.3
30 minutes after reperfusion 37.6  0.6 37.5  0.4 37.3  0.4 37.4  0.4
Blood gases§
pH, preischemia 7.40  0.02 7.39  0.03 7.38  0.02 7.39  0.02
PaCO2 (mm Hg) 43  2 40  3 42  3 40  2
PaO2 (mm Hg) 329  16 321  21 308  17 327  18
pH, reperfusion 7.14  0.02 7.17  0.02 7.19  0.02
PaCO2 (mm Hg) 35  2 35  3 36  2
PaO2 (mm Hg) 333  19 324  15 329  17
MABP, Distal mean arterial blood pressure, measured in tail artery.
*Rats injected with linolenic acid (250 nmol/kg) 30 minutes before aortic clamping.
†Rats injected with linolenic acid (250 nmol/kg) at onset of reperfusion.
‡MABP was measured just before aortic clamping, 5 minutes after onset of ischemia and after 30 minutes of reperfusion.
§Arterial blood gases were measured 10 minutes before initiation of ischemia and 10 minutes after onset of reperfusion. Physiologic data were analyzed with
one-way analysis of variance.
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All rats in the sham operation group had a normal
postoperative neurologic outcome, whereas all ischemic
rats had MSDI of 6 at 24 hours and remained severely
paraplegic throughout the observation period, with no
improvement in either sensory or motor function. Ischemic
rats had flaccid paraplegia after recovery from anesthesia,
and either spasticity developed within 6 hours or the rats
exhibited flaccid paraplegia until they were killed. All of
these rats also underwent urinary bladder dilation. Neuro-
logic outcome was significantly better in LIN-treated rats at
any time considered (Table II). All LIN-treated rats had
some form of flaccid paraplegia after recovery from anes-
thesia, but began to recover motor function between 3 and
6 hours postoperatively. After 7 days of reperfusion, only
10% of rats treated with LIN had severe paraplegia (Table
II).
Histopathology. Neuronal cell death was analyzed on
cresyl violet–stained sections (Fig 1). The extent of isch-
emic damage was grossly proportional to neurologic score.
Typical morphologic changes of necrosis appeared in isch-
emic rats. Injured spinal cord showed invasion of white
blood cells into gray matter and white matter, cellular
disruption and vacuolization of gray matter, presence of
shrunken necrotic neurons in ventral and dorsal horn gray
matter, and infiltration by polymorphonuclear neutrophils
and monocytes at 7 days after ischemia. Neurons also
demonstrated apoptotic features, such as shrinkage, chro-
matin condensation, and apoptotic bodies. Rats in the
sham operation group had normal spinal cords. The most
representative effects of LIN-treatment on morphologic
changes observed in the spinal cord after severe ischemia are
shown in Fig 1. All ischemic rats injected with vehicle had
severe ischemic injury, with global necrosis of gray matter.
In the most severe cases, white matter surrounding gray
matter was also damaged. LIN-treated rats with MSDI 0 to
2 showed either no or mild neuronal damage in gray
matter, predominantly in laminae 3 to 7 and 10. LIN-
treated rats with MSDI 3 or 4 exhibited variably sized
confluent necrotic areas, predominantly in laminae 3 to 7
and 10. Laminae 1 and 2 in dorsal horns and laminae 8 and
9 containing motor neurons were variably affected, de-
pending on neurologic status (Fig 1). Only a few large
motor neurons were injured in rats with MSDI 3, and less
than 50% were injured in rats with MSDI 4. After 7 days of
reperfusion the number of damaged neurons per section in
both groups of LIN-treated rats (LIN A and LIN B) was
significantly less than in vehicle-treated rats (Table III, A).
There was virtually no viable motor neuron in the ventral
horns of control rats, whereas most motor neurons re-
mained viable in both groups of rats LIN-treated rats
(Table IV).
TUNEL staining. Spinal cords from rats in the sham
operation group showed no evidence of TUNEL staining.
When treated with deoxyribonuclease, those cords demon-
strated TUNEL-stained nuclei (data not shown). Spinal
cord samples from ischemic rats injected with vehicle
showed numerous TUNEL-positive neurons scattered
within gray matter. The number of TUNEL-positive neu-
rons increased from ventral to dorsal. They were most
highly concentrated in laminae 1 and 2, then in laminae 3
to 7 and 10. Laminae 8 and 9 usually contained fewer
TUNEL-positive cells. Spinal cords from LIN-treated rats
with MSDI 0 to 3 showed few TUNEL-positive neurons
scattered within intermediate gray matter and dorsal horns,
depending on the neurologic status of the rat (Fig 2). There
were usually no TUNEL-positive neurons in ventral horns.
When MSDI was 4 to 6, numerous TUNEL-positive neu-
rons were detected in all gray matter, including ventral
horns. LIN injected 30 minutes before aortic clamping or
at onset of reperfusion strongly reduced the total number
of apoptotic neurons within gray matter, compared with
ischemic vehicle-treated rats (Fig 2; Table III, B).
Bax immunohistochemistry. Fig 3 shows the changes
at immunostaining of proapoptotic protein Bax with the
polyclonal anti-Bax antibody performed on spinal cord
sections of LIN-treated rats submitted to 14 minutes of
Table II. Neurologic score* (MSDI) after 24 hours and 7 days of reperfusion
MSDI
Sham operations Ischemia Lin A‡ Lin B§
24 hr
(n  15)
7 d
(n  15)
24 hr
(n  15)
7 days
(n  15)
24 hr
(n  15)
7 days
(n  15)
24 hours
(n  15)
7 days
(n  15)
0 15 15
1 2 4 1 2
2 2 1 4 2
3 2 2 2 2
4 5 4 4 5
5 4 4 2 1
6 15 15 2 3
MSDI, Motor sensory deficit index.
*Neurologic score adapted from LeMay et al (J Vass Surg 1987; 6:383–90) and involved a 7-point scale: 0, normal function; 6, severe paraplegia.
†Analyzed with Kruskal-Wallis test, followed by Mann-Whitney U test when significant.
‡Rats injected with linolenic acid (250 nmol/kg) 30 minutes before aortic clamping.
§Rats injected with linolenic acid (250 nmol/kg) at the onset of reperfusion.
P  0.05 vs ischemia. Neurologic status in Lin A and Lin B groups was significantly better than in ischemic group at 24 hours and 7 days, but Lin A and Lin
B groups did not differ significantly either at 24 hours or 7 days.
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Fig 1. Representative photomicrographs of lumbar spinal cord (L4) sections stained with cresyl violet from rats in
sham operation (B, C), ischemic (vehicle; A, D, E), and linolenic acid (LIN; F, G) treatment groups. Except for
rats who underwent sham operation, all rats underwent 14 minutes of ischemia and 7 days of reperfusion. Chosen
section for illustration of spinal cords in LIN-treated rats is from a rat with LeMay score of 1 that was treated at
onset of reperfusion. A, Overview of control spinal cord (25). B, D, F, High magnification of motor neurons in
ventral horn of sham operation, control, and LIN treatment groups, respectively (100). C, E, G, High
magnification of small neurons in dorsal horn of sham operation, control, and LIN treatment groups, respectively
(100).
JOURNAL OF VASCULAR SURGERY
September 2003568 Lang-Lazdunski et al
ischemia and observed at 24 hours after ischemia. Bax
remained poorly detectable in the spinal cords of rats 24
hours after sham surgery. Severe ischemia for 14 minutes
induced strong Bax immunoreactivity in numerous neu-
rons scattered in the gray matter of control rats, including
some motor neurons, 24 hours after the ischemic insult. In
contrast, injection of LIN after ischemia led to a significant
decrease in Bax expression in the spinal cords (Fig 3).
HSP70 immunohistochemistry. Fig 4 compares
HSP70 immunostaining in spinal cords of LIN-treated rats
submitted to severe ischemic injury and ischemic rats in-
jected with vehicle. Fourteen minutes of ischemia induced
HSP70 immunoreactivity in numerous neurons scattered
in the gray matter, but not in the nucleus of motor neurons
in control rats. In contrast, pretreatment or posttreatment
with LIN induced strong immunoreactivity for HSP70 in
the nucleus of motor neurons (Fig 4).
NF-B immunohistochemistry. Fig 5 depicts the in-
duction of NF-B protein in the spinal cord of rats after
severe ischemia and the effect of LIN treatment. Immuno-
staining was performed with a monoclonal antibody raised
against the active form of NF-B, 24 hours after the isch-
emic insult. Immunoreactivity to the activated form of
NF-B (p65 subunit) was not detectable in spinal cords of
rats who had undergone the sham operation. In contrast,
14 minutes of occlusion led to a strong increase in nuclear
staining of NF-B in neurons of dorsal and ventral spinal
cord, including motor neurons, whereas pretreatment or
posttreatment with LIN significantly reduced the immuno-
reactivity for NF-B observed in control rats (Fig 5).
DISCUSSION
Paraplegia resulting from spinal cord ischemia is a
dreaded complication of thoracic and thoracoabdominal
aortic surgery, despite various surgical adjuncts and phar-
macologic interventions.1,2 The rat model used in this
study was adapted from that of LeMay et al.7 The rat model
involving aortic clamping for 14 minutes is well established
and has been previously used for testing the potential
neuroprotective effect of drugs.10 It is highly reproducible,
because all ischemic rats operated on in strict normother-
mia and with aortic cross-clamping for 14 minutes had
severe and definitive paraplegia. Spinal cord arterial vascu-
larization is similar in rats and human beings, with a het-
erosegmental aorta and few anterior radicular arteries
reaching the anterior spinal artery.11 Combined clamping
of both aortic arch and left subclavian artery reproduces the
conditions encountered during repair of the descending
thoracic or thoracoabdominal aorta in human beings.12
The present study shows a major neuroprotective effect
of the N-3 PUFA LIN in an in vivo spinal cord ischemia
model. This PUFA, which is present in vegetable oils, has
already been reported neuroprotective in models of cere-
bral ischemia or kainate-induced epilepsy.5,6,13 LIN was
chosen because it clearly has the most potent neuroprotec-
tive effect of all PUFA in models of global ischemia and
epilepsy. Arachidonic acid, eicosapentaenoic acid, and do-
cosahexaenoic acid induce more limited neuroprotection in
both in vitro and in vivo models of ischemia.5 The dose and
route of LIN used in this study were chosen to obtain
maximal neuroprotective effect. In global cerebral ischemia
there is clearly a dose-response relationship between LIN
concentration and neuroprotection. An injected dose of
250 nmol/kg provides the best neuroprotective effect.5
The present study provides evidence that LIN is neuropro-
tective when administered prophylactively in a single intra-
venous dose. LIN also provides robust neuroprotection
when administered at the onset of reperfusion.
The neuroprotective effects of LIN treatment have also
been studied in terms of changes in protein expression after
ischemic injury. Expression of the apoptosis effector pro-
tein Bax and the nuclear transcription factor NF-B, known
to have a pivotal role in cell death and survival pathways, is
regarded as a diagnostic markes of neuronal cell death.
Although neuronal cell death carried by excitotoxic mech-
anisms has been classically attributed to necrosis, recent
reports demonstrate that apoptosis, a form of programmed
cell death, may also be triggered by excessive excitatory
amino acid release, free radical formation occurring after
spinal cord ischemia and reperfusion, or activation and
cleavage of caspases.14,15 The Bcl-2 family member Bax is a
potent proapoptotic molecule that, on translocation from
cytosol to mitochondria, triggers activation of terminal
Table III. Effects of linolenic acid treatment on number
of damaged neurons and TUNEL-positive cells in spinal
gray matter
Ischemia
(n  15)
LIN A
(n  15)
LIN B
(n  15)
A. Number (per cresyl violet-stained section) of damaged neurons
in laminae 1 to 10 of spinal gray matter 7 days after 14 minutes of
spinal cord ischemia
115  11 37  8* 40  7*
B. Number (per TUNEL-stained section) of TUNEL-positive
neurons in laminae 1 to 3 of the spinal gray matter 2 days after 14
minutes of spinal cord ischemia
36  7 5  2* 6  3*
Number of damaged neurons and TUNEL-positive per section is mean 
SD, and three sections were used for each animal (n 15, 10 slides per rat).
*P  .05 vs vehicle-treated ischemic rats (Ischemia).
Table IV. Effect of linolenic acid treatment on motor
neuron survival
Sham operation
(n  15)
Ischemia
(n  15)
LIN A
(n  15)
LIN B
(n  15)
26  3* 6  2 17  6* 15  7*
Effect of linolenic acid (LIN) on total number of intact large motor neurons
per section in ventral horns after 14 minutes of ischemia and 7 days of
reperfusion.
Number of intact motor neurons per section is mean  SD, and three
sections were used for each animal.
*P  .05 vs vehicle-treated ischemic rats (Ischemia).
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Fig 2. Representative photomicrographs of lumbar spinal cord (L4) show morphologic features of apoptosis with
TUNEL staining in sections from rats in sham operation (B, C), ischemic (vehicle; A, D, E), and linolenic acid (LIN;
F,G) treatment groups. Except for rats in the sham operation group, all rats underwent 14 minutes of ischemia and 24
hours of reperfusion. Chosen section for illustration of spinal cords in LIN-treated rats is from a rat with LeMay score
of 1 that was treated at onset of reperfusion. A, Overview of ischemic spinal cord (25) shows numerous TUNEL-
positive neurons scattered within gray matter (dorsal horn, intermediate gray matter, ventral horn). There are also some
TUNEL-positive motor neurons. B, D, F, High magnification of motor neurons in ventral horn of sham operation,
control, and LIN treatment group, respectively (100). C, E, G, High magnification of small neurons in dorsal horn
of sham operation, ischemic, and LIN treatment groups, respectively (100). F, G, Treatment with linolenic acid
resulted in a dramatic decrease in TUNEL labeling in almost the entire gray matter, especially the intermediate zone and
ventral horn.
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Fig 3. Immunohistochemical expression of Bax protein in lumbar spinal cord (L4) sections from rats in sham
operation (B, C), ischemic (vehicle; A, D, E), and linolenic acid (LIN; F, G) treatment groups. Except for rats in the
sham operation group, all rats underwent 14 minutes of ischemia and 24 hours of reperfusion. Chosen section for
illustration of spinal cords in LIN-treated rats is from a rat with LeMay score of 1 that was treated at onset of
reperfusion. A, Overview of Bax immunoreactivity in ishemic spinal cord (25). B, C, There was no Bax expression in
ventral and dorsal horns of rats in the sham operation group. A, D, E, After ischemia, intense Bax immunostaining was
observed in dorsal and ventral horn neurons. F, G, Spinal cords of LIN-treated rats exhibited complete loss of Bax
immunoreactivity in dorsal and ventral horns (100 magnification). Spinal cord frozen sections were prepared and
immunostained with polyclonal Bax antibody (see Material and Methods). Data are representative of four separate
experiments in each group (n  5).
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Fig 4. Immunohistochemical expression of HSP70 in lumbar spinal cord (L4) sections from rats in sham operation
(B, C, D), ischemic (vehicle; A, E, F, G), and linolenic acid (LIN; H, I, J) treatment groups. Except for rats in the
sham operation group, all rats underwent 14 minutes of ischemia and 24 hours of reperfusion. Chosen section for
illustration of spinal cords in LIN-treated rats is from a rat with LeMay score of 1 that was treated at onset of
reperfusion. A, Overview of HSP70 immunoreactivity in ischemic spinal cord (25). Ischemia induced HSP70
immunoreactivity in numerous neurons scattered in the gray matter of dorsal horns (G) and ventral horns (E), but not
in the nucleus of motor neurons of control rats (F). H, I, In contrast, linolenic acid induced strong immunoreactivity
for HSP70 in the nucleus of motor neurons. Magnification 100 for B, D, E, G, H and J, C, F, I corresponds to
respective photomicrographs B, E, H at higher magnification (500). Spinal cord frozen sections were prepared and
immunostained with polyclonal HSP70 antibody (see Material and Methods). Data are representative of four separate
experiments in each group (n  5).
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Fig 5. Immunohistochemical expression of NF-B protein in lumbar spinal cord (L4) sections from rats in sham
operation (B, C), ischemic (vehicle; A, D, E), and linolenic acid (LIN; F, G) treatment groups. Except for rats in the
sham operation group, all rats underwent 14 minutes of ischemia and 24 hours of reperfusion. Chosen section for
illustration of spinal cords in LIN-treated rats is from a rat with LeMay score of 1 that was treated at onset of
reperfusion. A, Overview of NF-B immunoreactivity in ischemic spinal cord (25). B, C, There was no NF-B
expression in ventral and dorsal horns of rats in the sham operation group. A, D, E, After ischemia, intense NF-B
immunostaining was observed in dorsal and ventral horn neurons. F, G, Spinal cords of LIN-treated rats exhibited an
important decrease in NF-B immunoreactivity in dorsal and ventral horns (100). Spinal cord frozen sections were
prepared and immunostained with monoclonal antibody of the active form of NF-B (see Material and Methods). Data
are representative of four separate experiments in each group (n  5).
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caspases by increasing mitochondrial membrane permeabil-
ity, and subsequently promotes delayed neuronal cell
death.16,17 The present study demonstrates that a single
dose of LIN injected intravenously before aortic clamping
or during reperfusion can prevent both necrosis and apo-
ptosis of spinal cord neurons. Thus neither consistent
TUNEL staining nor Bax immunoreactivity could be
detected in the spinal cord of most LIN-treated ani-
mals, attesting to robust protection against ischemia-
reperfusion–triggered neuronal apoptosis. Necrosis of
motor neurons was also prevented, or at least attenuated,
by LIN, as demonstrated by cresyl violet staining per-
formed after 7 days of reperfusion. This study also demon-
strates that LIN treatment prevents expression of NF-B
normally induced in the spinal cord of rats submitted to
severe ischemia. NF-B is an oxidative responsive transcrip-
tion factor that has a pivotal role in neuronal survival and
plasticity.18 It is activated by various signals, including
cytokines, neurotrophic factors, neurotransmitters, free
radicals, stimulation of glutamate receptors, and elevation
of intracellular calcium levels.19,20 Our results are in agree-
ment with recent studies that show a persistent increase in
active NF-B protein after ischemic and traumatic injury to
spinal cord.21,22
We also analyzed the effect of LIN treatment on ex-
pression of HSP70 in the spinal cord after severe ischemia.
The appearance of HSP70 immunoreactivity in the nucleus
of motor neurons is associated with survival of those neu-
rons. Heat shock proteins are a set of proteins expressed in
cells subjected to a variety of stresses, including hyperther-
mia, trauma, and ischemia.22,23 HSP70 has the ability to
prevent synthesis of abnormal proteins and to bind to
denatured or disrupted proteins until they are refolded or
degraded, thereby enabling recovery of motor neu-
rons.24,25 Recent studies have suggested that HSP70 may
have an important role in acquisition of ischemic tolerance
of motor neurons after sublethal ischemia.24,25
The precise mechanism of action of PUFA is unknown.
However, the key event in ischemia is generally accepted to
be excess glutamate liberation, associated with an excito-
toxic glutamate action that results in neuronal death, and it
is likely that PUFA are potent inhibitors of glutamatergic
neurotransmission and particularly of synaptic glutamate
release.5 PUFA display these blocking properties, probably
because they partially inhibit voltage-sensitive Na chan-
nels and voltage-sensitive Ca channels26 and, probably
more important, because they activate the background
TREK-1, TREK-2 and TRAAK channels. The recently
cloned TREK-1, TREK-2, and TRAAK channels are two-
pore domain background K channels potently activated
by arachidonic acid and other PUFA, but unaltered in their
function by saturated fatty acids.27-31 Recent electrophysi-
ologic recordings in cerebellar granule cells have provided
evidence that PUFA treatment results in opening of two-
pore domain background K channels.5 Activation of only
a small portion of TREK-1, TREK-2, and TRAAK channels
produces hyperpolarization of nerve terminals, which de-
creases glutamate release, and postsynaptic hyperpolariza-
tion, which reduces the excitotoxic effects of released glu-
tamate by counteracting the depolarizing effects of the
neurotransmitter and favoring the Mg blockade of the
N-methyl-D-aspartate receptor.5,32 The TRAAK channel is
highly expressed in spinal cord gray matter, the area most
susceptible to ischemia and excitotoxicity.29 This was an
important observation, leading us to propose that drugs
that activate TRAAK channels might be useful for spinal
cord gray matter protection against ischemia and excito-
toxic injury. Of interest, another activator of TREK-1,
TREK-2, and more specifically TRAAK channels is riluzole,
a drug that has demonstrated major neuroprotective effects
in spinal cord ischemia models.3,10,33
Neither perioperative hypothermia nor increase in ar-
terial blood pressure can account for the protective effect of
LIN observed in this study, because rectal temperature and
arterial blood pressure were closely monitored and did not
differ among experimental groups. No major side effect was
associated with LIN. We anticipate that LIN might have
important implications in clinical situations requiring pro-
longed cross-clamping of the descending thoracic aorta,
which potentially can trigger ischemia and reperfusion in
the spinal cord. In these particular situations, a single
injection of LIN before aortic clamping or before hypo-
thermic circulatory arrest might prevent both necrosis and
apoptosis of spinal cord neurons by extending their isch-
emic tolerance before adequate spinal cord perfusion can be
reestablished. We also tested LIN at onset of reperfusion to
demonstrate that administration of this drug can be delayed
up to completion of aortic aneurysm repair, particularly in
emergency cases (eg, ruptured aneurysm), when spinal cord
ischemia is most likely and when it is most urgent that the
thoracic aorta be clamped to stop hemorrhage and proceed
with aortic repair. In such cases the anesthesiologist can
inject LIN while the surgeon is completing aortic replace-
ment. We also postulate that LIN injection can be used
with cerebrospinal fluid drainage if delayed paraplegia oc-
curs after thoracoabdominal aortic graft replacement.
LIN provides robust protection against neuronal ne-
crosis and apoptosis in a rat model of spinal cord ischemia.
We anticipate that LIN may have important clinical impli-
cations during high-risk surgical procedures on the de-
scending thoracic or thoracoabdominal aorta in human
beings.
We thank C. Widmann, I. Lemasson, F. Aguila, and V.
Lopez for technical assistance.
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